Stock A072020 CHOONG ANG VACCINE LABORATORY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Choong Ang Vaccine Laboratory Co., Ltd.

Equities

A072020

KR7072020001

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-02 EDT 		5-day change 1st Jan Change
10,700 KRW 0.00% Intraday chart for Choong Ang Vaccine Laboratory Co., Ltd. -4.97% -2.82%
05-10 Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares. CI
05-10 Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares.
CI
Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan.
CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Tranche Update on Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan announced on October 13, 2022.
CI
Tranche Update on Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan announced on October 13, 2022.
CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback announced on October 13, 2022, has closed with 100,000 shares, representing 1.03% for KRW 1,121.97 million.
CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares.
CI
Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan.
CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback announced on October 8, 2021, has expired.
CI
Choong Ang Vaccine Laboratory Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares.
CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan Shortened to January 7, 2022.
CI
Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan.
CI
Tranche Update on Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback Plan announced on March 13, 2020.
CI
Choong Ang Vaccine Laboratory Co., Ltd.'s Equity Buyback announced on March 13, 2020 has closed with 100,000 shares, representing 1% for KRW 1,385.28 million.
CI
Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares.
CI
Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A072020 Stock
  4. News Choong Ang Vaccine Laboratory Co., Ltd.
  5. Highlights